Shared on05 Sep 25
With both the discount rate and future P/E ratio essentially unchanged, Surgical Science Sweden's fair value remains steady at SEK163.00. Valuation Changes Summary of Valuation Changes for Surgical Science Sweden The Consensus Analyst Price Target remained effectively unchanged, at SEK163.00.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 15%
AnalystConsensusTarget has increased future PE multiple from 23.7x to 27.6x.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Increased 1.79%
AnalystConsensusTarget has decreased profit margin from 29.9% to 24.0% and increased future PE multiple from 24.4x to 29.9x.